Continuous Expression of Bcl-xL Protein During Megakaryopoiesis is Post-translationally Regulated by Thrombopoietin-mediated Akt Activation, Which Prevents the Cleavage of Bcl-xL
Overview
Authors
Affiliations
Background: One of the important biological activities of thrombopoietin (TPO) is to prevent the apoptosis of megakaryocytes. As the antiapoptotic protein Bcl-xL, which has been proven to be indispensable for erythroid differentiation, is also abundantly expressed in megakaryocytes, it is assumed that Bcl-xL plays an important role in megakaryopoiesis.
Objectives: We investigated the expression of Bcl-xL during megakaryopoiesis and the underlying regulatory mechanism.
Methods And Results: In stem cell-derived megakaryocytes, expression of Bcl-xL increased in the early and mid-stages of the differentiation. Both in vitro in cell culture and in vivo in an animal model, expression of Bcl-xL protein was maintained until the platelet-producing stage. TPO depletion caused significant decrease in Bcl-xL protein level without affecting its mRNA in both megakaryocytes and TPO-dependent megakaryocytic UT-7/TPO cells, suggesting that Bcl-xL protein level in TPO-dependent cells is post-translationally regulated. In agreement with this finding, we recognized the appearance of a 12-kD fragment of Bcl-xL upon TPO depletion. This cleavage of Bcl-xL was inhibited by a caspase-3-specific inhibitor. Furthermore, pretreatment of UT-7/TPO with a phosphatidylinositol 3-kinase (PI3 K) inhibitor resulted in the cleavage of Bcl-xL even in the presence of TPO. We thus hypothesized that PI3 K inhibits the activation of caspase-3 and consequent cleavage of Bcl-xL. To prove this, we prepared UT-7/TPO cells transfected with constitutively active Akt-1. When TPO was depleted, the transfectant was significantly less liable to caspase-3 activation and Bcl-xL cleavage.
Conclusions: Bcl-xL protein is expressed throughout megakaryopoiesis until platelets are produced, and its expression level is at least in part post-translationally regulated through TPO-mediated Akt activation.
Ranjit S, Wang Y, Zhu J, Cheepala S, Schuetz E, Cho W Drug Resist Updat. 2023; 72:101017.
PMID: 37988981 PMC: 10874622. DOI: 10.1016/j.drup.2023.101017.
Apoptosis: role in myeloid cell development.
Sarvothaman S, Undi R, Pasupuleti S, Gutti U, Gutti R Blood Res. 2015; 50(2):73-9.
PMID: 26157776 PMC: 4486162. DOI: 10.5045/br.2015.50.2.73.
Avanzi M, Izak M, Oluwadara O, Mitchell W PLoS One. 2015; 10(4):e0125057.
PMID: 25875470 PMC: 4397066. DOI: 10.1371/journal.pone.0125057.
Abd-Elrahman I, Deutsch V, Pick M, Kay S, Neuman T, Perlman R Cell Death Dis. 2013; 4:e937.
PMID: 24287698 PMC: 3847330. DOI: 10.1038/cddis.2013.454.
Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages.
Kodama T, Hikita H, Kawaguchi T, Shigekawa M, Shimizu S, Hayashi Y Cell Death Differ. 2012; 19(11):1856-69.
PMID: 22790873 PMC: 3469054. DOI: 10.1038/cdd.2012.88.